Global Poliomyelitis Vaccines Market Growth 2023-2029

SKU ID : LPI-22789254 | Publishing Date : 01-Mar-2023 | No. of pages : 93

Detailed TOC of Global Poliomyelitis Vaccines Market Growth 2023-2029

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Poliomyelitis Vaccines Annual Sales 2018-2029
        2.1.2 World Current & Future Analysis for Poliomyelitis Vaccines by Geographic Region, 2018, 2022 & 2029
        2.1.3 World Current & Future Analysis for Poliomyelitis Vaccines by Country/Region, 2018, 2022 & 2029
    2.2 Poliomyelitis Vaccines Segment by Type
        2.2.1 IPV
        2.2.2 OPV
    2.3 Poliomyelitis Vaccines Sales by Type
        2.3.1 Global Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
        2.3.2 Global Poliomyelitis Vaccines Revenue and Market Share by Type (2018-2023)
        2.3.3 Global Poliomyelitis Vaccines Sale Price by Type (2018-2023)
    2.4 Poliomyelitis Vaccines Segment by Application
        2.4.1 Research & Academic Laboratories
        2.4.2 Pharmaceutical & Biotechnology Companies
        2.4.3 Others
    2.5 Poliomyelitis Vaccines Sales by Application
        2.5.1 Global Poliomyelitis Vaccines Sale Market Share by Application (2018-2023)
        2.5.2 Global Poliomyelitis Vaccines Revenue and Market Share by Application (2018-2023)
        2.5.3 Global Poliomyelitis Vaccines Sale Price by Application (2018-2023)
3 Global Poliomyelitis Vaccines by Company
    3.1 Global Poliomyelitis Vaccines Breakdown Data by Company
        3.1.1 Global Poliomyelitis Vaccines Annual Sales by Company (2018-2023)
        3.1.2 Global Poliomyelitis Vaccines Sales Market Share by Company (2018-2023)
    3.2 Global Poliomyelitis Vaccines Annual Revenue by Company (2018-2023)
        3.2.1 Global Poliomyelitis Vaccines Revenue by Company (2018-2023)
        3.2.2 Global Poliomyelitis Vaccines Revenue Market Share by Company (2018-2023)
    3.3 Global Poliomyelitis Vaccines Sale Price by Company
    3.4 Key Manufacturers Poliomyelitis Vaccines Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Poliomyelitis Vaccines Product Location Distribution
        3.4.2 Players Poliomyelitis Vaccines Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Poliomyelitis Vaccines by Geographic Region
    4.1 World Historic Poliomyelitis Vaccines Market Size by Geographic Region (2018-2023)
        4.1.1 Global Poliomyelitis Vaccines Annual Sales by Geographic Region (2018-2023)
        4.1.2 Global Poliomyelitis Vaccines Annual Revenue by Geographic Region (2018-2023)
    4.2 World Historic Poliomyelitis Vaccines Market Size by Country/Region (2018-2023)
        4.2.1 Global Poliomyelitis Vaccines Annual Sales by Country/Region (2018-2023)
        4.2.2 Global Poliomyelitis Vaccines Annual Revenue by Country/Region (2018-2023)
    4.3 Americas Poliomyelitis Vaccines Sales Growth
    4.4 APAC Poliomyelitis Vaccines Sales Growth
    4.5 Europe Poliomyelitis Vaccines Sales Growth
    4.6 Middle East & Africa Poliomyelitis Vaccines Sales Growth
5 Americas
    5.1 Americas Poliomyelitis Vaccines Sales by Country
        5.1.1 Americas Poliomyelitis Vaccines Sales by Country (2018-2023)
        5.1.2 Americas Poliomyelitis Vaccines Revenue by Country (2018-2023)
    5.2 Americas Poliomyelitis Vaccines Sales by Type
    5.3 Americas Poliomyelitis Vaccines Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Poliomyelitis Vaccines Sales by Region
        6.1.1 APAC Poliomyelitis Vaccines Sales by Region (2018-2023)
        6.1.2 APAC Poliomyelitis Vaccines Revenue by Region (2018-2023)
    6.2 APAC Poliomyelitis Vaccines Sales by Type
    6.3 APAC Poliomyelitis Vaccines Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Poliomyelitis Vaccines by Country
        7.1.1 Europe Poliomyelitis Vaccines Sales by Country (2018-2023)
        7.1.2 Europe Poliomyelitis Vaccines Revenue by Country (2018-2023)
    7.2 Europe Poliomyelitis Vaccines Sales by Type
    7.3 Europe Poliomyelitis Vaccines Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Poliomyelitis Vaccines by Country
        8.1.1 Middle East & Africa Poliomyelitis Vaccines Sales by Country (2018-2023)
        8.1.2 Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2018-2023)
    8.2 Middle East & Africa Poliomyelitis Vaccines Sales by Type
    8.3 Middle East & Africa Poliomyelitis Vaccines Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Poliomyelitis Vaccines
    10.3 Manufacturing Process Analysis of Poliomyelitis Vaccines
    10.4 Industry Chain Structure of Poliomyelitis Vaccines
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Poliomyelitis Vaccines Distributors
    11.3 Poliomyelitis Vaccines Customer
12 World Forecast Review for Poliomyelitis Vaccines by Geographic Region
    12.1 Global Poliomyelitis Vaccines Market Size Forecast by Region
        12.1.1 Global Poliomyelitis Vaccines Forecast by Region (2024-2029)
        12.1.2 Global Poliomyelitis Vaccines Annual Revenue Forecast by Region (2024-2029)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Poliomyelitis Vaccines Forecast by Type
    12.7 Global Poliomyelitis Vaccines Forecast by Application
13 Key Players Analysis
    13.1 Sanofi
        13.1.1 Sanofi Company Information
        13.1.2 Sanofi Poliomyelitis Vaccines Product Portfolios and Specifications
        13.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.1.4 Sanofi Main Business Overview
        13.1.5 Sanofi Latest Developments
    13.2 GSK
        13.2.1 GSK Company Information
        13.2.2 GSK Poliomyelitis Vaccines Product Portfolios and Specifications
        13.2.3 GSK Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.2.4 GSK Main Business Overview
        13.2.5 GSK Latest Developments
    13.3 Bibcol
        13.3.1 Bibcol Company Information
        13.3.2 Bibcol Poliomyelitis Vaccines Product Portfolios and Specifications
        13.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.3.4 Bibcol Main Business Overview
        13.3.5 Bibcol Latest Developments
    13.4 Serum Institute
        13.4.1 Serum Institute Company Information
        13.4.2 Serum Institute Poliomyelitis Vaccines Product Portfolios and Specifications
        13.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.4.4 Serum Institute Main Business Overview
        13.4.5 Serum Institute Latest Developments
    13.5 Tiantan Biological
        13.5.1 Tiantan Biological Company Information
        13.5.2 Tiantan Biological Poliomyelitis Vaccines Product Portfolios and Specifications
        13.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.5.4 Tiantan Biological Main Business Overview
        13.5.5 Tiantan Biological Latest Developments
    13.6 IMBCA
        13.6.1 IMBCA Company Information
        13.6.2 IMBCA Poliomyelitis Vaccines Product Portfolios and Specifications
        13.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.6.4 IMBCA Main Business Overview
        13.6.5 IMBCA Latest Developments
    13.7 Panacea Biotec Ltd
        13.7.1 Panacea Biotec Ltd Company Information
        13.7.2 Panacea Biotec Ltd Poliomyelitis Vaccines Product Portfolios and Specifications
        13.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.7.4 Panacea Biotec Ltd Main Business Overview
        13.7.5 Panacea Biotec Ltd Latest Developments
    13.8 Bio-Med
        13.8.1 Bio-Med Company Information
        13.8.2 Bio-Med Poliomyelitis Vaccines Product Portfolios and Specifications
        13.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.8.4 Bio-Med Main Business Overview
        13.8.5 Bio-Med Latest Developments
    13.9 Halfkin Bio-Pharmaceuticals
        13.9.1 Halfkin Bio-Pharmaceuticals Company Information
        13.9.2 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Portfolios and Specifications
        13.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
        13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
        13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Figures, Tables and Charts Available in Global Poliomyelitis Vaccines Market Growth 2023-2029

List of Tables
    Table 1. Poliomyelitis Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Poliomyelitis Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of IPV
    Table 4. Major Players of OPV
    Table 5. Global Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
    Table 6. Global Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
    Table 7. Global Poliomyelitis Vaccines Revenue by Type (2018-2023) & ($ million)
    Table 8. Global Poliomyelitis Vaccines Revenue Market Share by Type (2018-2023)
    Table 9. Global Poliomyelitis Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
    Table 10. Global Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
    Table 11. Global Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
    Table 12. Global Poliomyelitis Vaccines Revenue by Application (2018-2023)
    Table 13. Global Poliomyelitis Vaccines Revenue Market Share by Application (2018-2023)
    Table 14. Global Poliomyelitis Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
    Table 15. Global Poliomyelitis Vaccines Sales by Company (2018-2023) & (K Units)
    Table 16. Global Poliomyelitis Vaccines Sales Market Share by Company (2018-2023)
    Table 17. Global Poliomyelitis Vaccines Revenue by Company (2018-2023) ($ Millions)
    Table 18. Global Poliomyelitis Vaccines Revenue Market Share by Company (2018-2023)
    Table 19. Global Poliomyelitis Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
    Table 20. Key Manufacturers Poliomyelitis Vaccines Producing Area Distribution and Sales Area
    Table 21. Players Poliomyelitis Vaccines Products Offered
    Table 22. Poliomyelitis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Poliomyelitis Vaccines Sales by Geographic Region (2018-2023) & (K Units)
    Table 26. Global Poliomyelitis Vaccines Sales Market Share Geographic Region (2018-2023)
    Table 27. Global Poliomyelitis Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 28. Global Poliomyelitis Vaccines Revenue Market Share by Geographic Region (2018-2023)
    Table 29. Global Poliomyelitis Vaccines Sales by Country/Region (2018-2023) & (K Units)
    Table 30. Global Poliomyelitis Vaccines Sales Market Share by Country/Region (2018-2023)
    Table 31. Global Poliomyelitis Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
    Table 32. Global Poliomyelitis Vaccines Revenue Market Share by Country/Region (2018-2023)
    Table 33. Americas Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
    Table 34. Americas Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
    Table 35. Americas Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 36. Americas Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
    Table 37. Americas Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
    Table 38. Americas Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
    Table 39. APAC Poliomyelitis Vaccines Sales by Region (2018-2023) & (K Units)
    Table 40. APAC Poliomyelitis Vaccines Sales Market Share by Region (2018-2023)
    Table 41. APAC Poliomyelitis Vaccines Revenue by Region (2018-2023) & ($ Millions)
    Table 42. APAC Poliomyelitis Vaccines Revenue Market Share by Region (2018-2023)
    Table 43. APAC Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
    Table 44. APAC Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
    Table 45. Europe Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
    Table 46. Europe Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
    Table 47. Europe Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 48. Europe Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
    Table 49. Europe Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
    Table 50. Europe Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
    Table 51. Middle East & Africa Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
    Table 52. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
    Table 53. Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 54. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
    Table 55. Middle East & Africa Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
    Table 56. Middle East & Africa Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
    Table 57. Key Market Drivers & Growth Opportunities of Poliomyelitis Vaccines
    Table 58. Key Market Challenges & Risks of Poliomyelitis Vaccines
    Table 59. Key Industry Trends of Poliomyelitis Vaccines
    Table 60. Poliomyelitis Vaccines Raw Material
    Table 61. Key Suppliers of Raw Materials
    Table 62. Poliomyelitis Vaccines Distributors List
    Table 63. Poliomyelitis Vaccines Customer List
    Table 64. Global Poliomyelitis Vaccines Sales Forecast by Region (2024-2029) & (K Units)
    Table 65. Global Poliomyelitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 66. Americas Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
    Table 67. Americas Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 68. APAC Poliomyelitis Vaccines Sales Forecast by Region (2024-2029) & (K Units)
    Table 69. APAC Poliomyelitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 70. Europe Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
    Table 71. Europe Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 72. Middle East & Africa Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
    Table 73. Middle East & Africa Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. Global Poliomyelitis Vaccines Sales Forecast by Type (2024-2029) & (K Units)
    Table 75. Global Poliomyelitis Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 76. Global Poliomyelitis Vaccines Sales Forecast by Application (2024-2029) & (K Units)
    Table 77. Global Poliomyelitis Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 78. Sanofi Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 79. Sanofi Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 80. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 81. Sanofi Main Business
    Table 82. Sanofi Latest Developments
    Table 83. GSK Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 84. GSK Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 85. GSK Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 86. GSK Main Business
    Table 87. GSK Latest Developments
    Table 88. Bibcol Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 89. Bibcol Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 90. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 91. Bibcol Main Business
    Table 92. Bibcol Latest Developments
    Table 93. Serum Institute Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 94. Serum Institute Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 95. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 96. Serum Institute Main Business
    Table 97. Serum Institute Latest Developments
    Table 98. Tiantan Biological Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 99. Tiantan Biological Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 100. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 101. Tiantan Biological Main Business
    Table 102. Tiantan Biological Latest Developments
    Table 103. IMBCA Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 104. IMBCA Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 105. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 106. IMBCA Main Business
    Table 107. IMBCA Latest Developments
    Table 108. Panacea Biotec Ltd Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 109. Panacea Biotec Ltd Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 110. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 111. Panacea Biotec Ltd Main Business
    Table 112. Panacea Biotec Ltd Latest Developments
    Table 113. Bio-Med Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 114. Bio-Med Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 115. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 116. Bio-Med Main Business
    Table 117. Bio-Med Latest Developments
    Table 118. Halfkin Bio-Pharmaceuticals Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 119. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Portfolios and Specifications
    Table 120. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 121. Halfkin Bio-Pharmaceuticals Main Business
    Table 122. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
    Figure 1. Picture of Poliomyelitis Vaccines
    Figure 2. Poliomyelitis Vaccines Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Poliomyelitis Vaccines Sales Growth Rate 2018-2029 (K Units)
    Figure 7. Global Poliomyelitis Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Poliomyelitis Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of IPV
    Figure 10. Product Picture of OPV
    Figure 11. Global Poliomyelitis Vaccines Sales Market Share by Type in 2022
    Figure 12. Global Poliomyelitis Vaccines Revenue Market Share by Type (2018-2023)
    Figure 13. Poliomyelitis Vaccines Consumed in Research & Academic Laboratories
    Figure 14. Global Poliomyelitis Vaccines Market: Research & Academic Laboratories (2018-2023) & (K Units)
    Figure 15. Poliomyelitis Vaccines Consumed in Pharmaceutical & Biotechnology Companies
    Figure 16. Global Poliomyelitis Vaccines Market: Pharmaceutical & Biotechnology Companies (2018-2023) & (K Units)
    Figure 17. Poliomyelitis Vaccines Consumed in Others
    Figure 18. Global Poliomyelitis Vaccines Market: Others (2018-2023) & (K Units)
    Figure 19. Global Poliomyelitis Vaccines Sales Market Share by Application (2022)
    Figure 20. Global Poliomyelitis Vaccines Revenue Market Share by Application in 2022
    Figure 21. Poliomyelitis Vaccines Sales Market by Company in 2022 (K Units)
    Figure 22. Global Poliomyelitis Vaccines Sales Market Share by Company in 2022
    Figure 23. Poliomyelitis Vaccines Revenue Market by Company in 2022 ($ Million)
    Figure 24. Global Poliomyelitis Vaccines Revenue Market Share by Company in 2022
    Figure 25. Global Poliomyelitis Vaccines Sales Market Share by Geographic Region (2018-2023)
    Figure 26. Global Poliomyelitis Vaccines Revenue Market Share by Geographic Region in 2022
    Figure 27. Americas Poliomyelitis Vaccines Sales 2018-2023 (K Units)
    Figure 28. Americas Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
    Figure 29. APAC Poliomyelitis Vaccines Sales 2018-2023 (K Units)
    Figure 30. APAC Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
    Figure 31. Europe Poliomyelitis Vaccines Sales 2018-2023 (K Units)
    Figure 32. Europe Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
    Figure 33. Middle East & Africa Poliomyelitis Vaccines Sales 2018-2023 (K Units)
    Figure 34. Middle East & Africa Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
    Figure 35. Americas Poliomyelitis Vaccines Sales Market Share by Country in 2022
    Figure 36. Americas Poliomyelitis Vaccines Revenue Market Share by Country in 2022
    Figure 37. Americas Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
    Figure 38. Americas Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
    Figure 39. United States Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Canada Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Mexico Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 42. Brazil Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 43. APAC Poliomyelitis Vaccines Sales Market Share by Region in 2022
    Figure 44. APAC Poliomyelitis Vaccines Revenue Market Share by Regions in 2022
    Figure 45. APAC Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
    Figure 46. APAC Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
    Figure 47. China Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 48. Japan Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 49. South Korea Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Southeast Asia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 51. India Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 52. Australia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 53. China Taiwan Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 54. Europe Poliomyelitis Vaccines Sales Market Share by Country in 2022
    Figure 55. Europe Poliomyelitis Vaccines Revenue Market Share by Country in 2022
    Figure 56. Europe Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
    Figure 57. Europe Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
    Figure 58. Germany Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 59. France Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 60. UK Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Italy Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Russia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 63. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Country in 2022
    Figure 64. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Country in 2022
    Figure 65. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
    Figure 66. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
    Figure 67. Egypt Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 68. South Africa Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Israel Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Turkey Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 71. GCC Country Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 72. Manufacturing Cost Structure Analysis of Poliomyelitis Vaccines in 2022
    Figure 73. Manufacturing Process Analysis of Poliomyelitis Vaccines
    Figure 74. Industry Chain Structure of Poliomyelitis Vaccines
    Figure 75. Channels of Distribution
    Figure 76. Global Poliomyelitis Vaccines Sales Market Forecast by Region (2024-2029)
    Figure 77. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Region (2024-2029)
    Figure 78. Global Poliomyelitis Vaccines Sales Market Share Forecast by Type (2024-2029)
    Figure 79. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Type (2024-2029)
    Figure 80. Global Poliomyelitis Vaccines Sales Market Share Forecast by Application (2024-2029)
    Figure 81. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Application (2024-2029)